BR0014150A - Diagnósticos e terapêuticos para osteoporose - Google Patents

Diagnósticos e terapêuticos para osteoporose

Info

Publication number
BR0014150A
BR0014150A BR0014150-0A BR0014150A BR0014150A BR 0014150 A BR0014150 A BR 0014150A BR 0014150 A BR0014150 A BR 0014150A BR 0014150 A BR0014150 A BR 0014150A
Authority
BR
Brazil
Prior art keywords
osteoporosis
therapeutics
diagnostics
diagnoses
therapies
Prior art date
Application number
BR0014150-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Simon Van Dijk
Gordonw Duff
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of BR0014150A publication Critical patent/BR0014150A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0014150-0A 1999-08-30 2000-08-30 Diagnósticos e terapêuticos para osteoporose BR0014150A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15146099P 1999-08-30 1999-08-30
PCT/US2000/023844 WO2001016377A2 (en) 1999-08-30 2000-08-30 Diagnostics and therapeutics for osteoporosis

Publications (1)

Publication Number Publication Date
BR0014150A true BR0014150A (pt) 2002-05-14

Family

ID=22538869

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014150-0A BR0014150A (pt) 1999-08-30 2000-08-30 Diagnósticos e terapêuticos para osteoporose

Country Status (11)

Country Link
US (2) US6558905B1 (enExample)
EP (1) EP1212464B1 (enExample)
JP (1) JP2004504802A (enExample)
AT (1) ATE318328T1 (enExample)
AU (2) AU785040B2 (enExample)
BR (1) BR0014150A (enExample)
CA (1) CA2382848C (enExample)
DE (1) DE60026150T2 (enExample)
ES (1) ES2261239T3 (enExample)
MX (1) MXPA02002251A (enExample)
WO (1) WO2001016377A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000880A2 (en) * 1999-06-30 2001-01-04 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
EP1409737A4 (en) * 2001-06-15 2005-10-12 Interleukin Genetics Inc METHODS OF DETECTING AND TREATING EARLY APPEARANCE OF CONDITIONS RELATED TO AGING
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CN1751127A (zh) * 2002-01-25 2006-03-22 白介素遗传公司 Il－1基因簇和相关的炎性多态性和单倍型
AU2003265676A1 (en) * 2002-08-24 2004-03-11 Creighton University Methods for detecting genes associated with bone properties and/or height
CA2512549A1 (en) * 2003-01-16 2004-08-05 Decode Genetics Ehf. Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
AU2004263184B2 (en) * 2003-08-08 2010-12-02 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
RU2271827C1 (ru) * 2004-09-28 2006-03-20 Федеральное государственное учреждение"Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи Федерального агенства по здравоохранению и социальному развитию"(ФГУ "СПбНИИ ЛОР Росздрава") Способ определения тактики лечения рекомбинантным цитокином, регулирующим воспаление
US7353662B2 (en) * 2004-12-22 2008-04-08 York International Corporation Medium voltage starter for a chiller unit
US8590329B2 (en) 2004-12-22 2013-11-26 Johnson Controls Technology Company Medium voltage power controller
EP1951903A2 (en) * 2005-10-25 2008-08-06 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
EP2089538B1 (en) * 2006-11-15 2013-08-21 Interleukin Genetics, Inc. The il-1 gene cluster and insulin resistance: associated polymorphisms, haplotypes and methods of using same
CA3011363A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3980561A1 (en) 2019-06-06 2022-04-13 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
US5593833A (en) 1992-07-31 1997-01-14 Garvan Institute Of Medical Research Assessment of allelic variation in vitamin D receptor correlated to bone density or turnover
DE69333641T2 (de) 1992-12-28 2005-11-03 Baylink, David Jeston, Redlands Methode zur messung der knochenresorption
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
ATE318328T1 (de) 2006-03-15
AU2006203097A1 (en) 2006-08-17
CA2382848C (en) 2011-01-04
AU7338000A (en) 2001-03-26
WO2001016377A3 (en) 2002-01-17
AU785040B2 (en) 2006-08-31
WO2001016377A2 (en) 2001-03-08
EP1212464A2 (en) 2002-06-12
US6558905B1 (en) 2003-05-06
AU2006203097B2 (en) 2009-03-12
JP2004504802A (ja) 2004-02-19
EP1212464B1 (en) 2006-02-22
DE60026150D1 (de) 2006-04-27
MXPA02002251A (es) 2003-08-20
ES2261239T3 (es) 2006-11-16
DE60026150T2 (de) 2006-11-16
US20040110168A1 (en) 2004-06-10
CA2382848A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
EP1124598A4 (en) SYSTEM FOR DIAGNOSING URINARY INCONTINENCE
DE69933661D1 (de) Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
EP1461061A4 (en) COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
WO2004096842A3 (en) Sars virus nucleotide and amino acid sequences and uses thereof
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
WO2003078574A3 (en) Novel metabolic targets and markers
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
WO2000034511A3 (de) Peptid screening test zum nachweis von ass
ATE490339T1 (de) Diagnostikum für osteoporose
ATE369429T1 (de) Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
WO2004083241A3 (en) Btc-interacting proteins and use thereof
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
GB9811221D0 (en) Bacterial-pheromones and uses therefor
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
NZ514691A (en) Method to type prion proteins
EP0854186A3 (en) Staphylococcus aureus cell division gene DivIB
ATE374260T1 (de) Asthma-assoziiertes gen
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii
WO2002088345A3 (en) Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
WO2003025198A3 (en) Regulatory single nucleotide polymorphisms and methods therefor
GR1005061B (el) Πρωτεινες με προγνωστικη, διαγνωστικη και θεραπευτικη σημασια για την τρισωμια 21 (συνδρομο down)

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]